Addressing racial disparities in skin cancer involves education, understanding rates of risk and ethnicity, and knowledge of the different types of melanoma, which makes skin cancer disparities complex to attack, said Sancy Leachman, MD, PhD, professor and chair in the Department of Dermatology and director of the Melanoma Research Program at the Knight Cancer Institute at Oregon Health and Science University.
2023
Closing Thoughts on Intralesional Therapy for Melanoma and CSCC
Sunandana Chandra, MD, MS: Dr Pavlick, given the logistical challenges of delivering intralesional therapies, can you describe the way your practice does it so our audience can glean some tips as they try to develop these in their own institutions and hospitals?
Nasal Administration of Novel Recombinant Protozoan Strain Prevents Metastatic Melanoma in the Lung
The protozoan intranasal treatment was associated with a strong increase of immune cells within the lung.
Imiquimod efficacious in melanoma in situ tumor reduction
Imiquimod treatment for 16 weeks exhibited a 90% tumor clearance rate in persistent MMIS at margins of resection.